Naloxone, but not valsartan, preserves responses to hypoglycemia after antecedent hypoglycemia: role of metabolic reprogramming in counterregulatory failure.

Naloxone, but not valsartan, preserves responses to hypoglycemia after antecedent hypoglycemia: role of metabolic reprogramming in counterregulatory failure.

Item
http://www.wikidata.org/entity/Q34448782
Role of the hypothalamus in mediating protective effects of dietary restriction during agingRegulation of peripheral metabolism by substrate partitioning in the brain.Challenges in Modelling Hypoglycaemia-Associated Autonomic Failure: A Review of Human and Animal StudiesElimination of hypoglycemia from the lives of people affected by diabetes.Opioid receptor blockade improves hypoglycemia-associated autonomic failure in type 1 diabetes mellitus.Magnitude of exercise-induced β-endorphin response is associated with subsequent development of altered hypoglycemia counterregulation.Opioid receptor blockade prevents exercise-associated autonomic failure in humans.Defective counterregulation and hypoglycemia unawareness in diabetes: mechanisms and emerging treatments.Hypothalamic EphA5 facilitates counterregulatory responses: possible role for bidirectional signaling leading to bistability that enhances responsiveness to hypoglycemia.Naltrexone for treatment of impaired awareness of hypoglycemia in type 1 diabetes: A randomized clinical trial.Plasma sphingolipids are biomarkers of metabolic syndrome in non-human primates maintained on a Western-style diet.Metabolic mystery: aging, obesity, diabetes, and the ventromedial hypothalamus.Evaluation of the counter-regulatory responses to hypoglycaemia in patients with type 1 diabetes during opiate receptor blockade with naltrexone.Glucose-Induced Transcriptional Hysteresis: Role in Obesity, Metabolic Memory, Diabetes, and Aging.
P2860

Naloxone, but not valsartan, preserves responses to hypoglycemia after antecedent hypoglycemia: role of metabolic reprogramming in counterregulatory failure.

Item
http://www.wikidata.org/entity/Q34448782
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Naloxone, but not valsartan, p ...... in counterregulatory failure.
@ast
Naloxone, but not valsartan, p ...... in counterregulatory failure.
@en
Naloxone, but not valsartan, p ...... in counterregulatory failure.
@nl
type
label
Naloxone, but not valsartan, p ...... in counterregulatory failure.
@ast
Naloxone, but not valsartan, p ...... in counterregulatory failure.
@en
Naloxone, but not valsartan, p ...... in counterregulatory failure.
@nl
prefLabel
Naloxone, but not valsartan, p ...... in counterregulatory failure.
@ast
Naloxone, but not valsartan, p ...... in counterregulatory failure.
@en
Naloxone, but not valsartan, p ...... in counterregulatory failure.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Naloxone, but not valsartan, p ...... g in counterregulatory failure
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932